|
GS135359: B.burgdorferi-associated arthritis 17 (Bbaa17, Published QTL Chr 9)
|
|
GS192691: GO:0015630 microtubule cytoskeleton
|
|
GS135884: femur geometry 8 (Fmgty8, Published QTL Chr 9)
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS128598: Ethanol Induced Ataxia Chr#9
|
|
GS178359: GO:0071840 cellular component organization or biogenesis
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS84232: cocaine related behavior (Published QTL, Chr 9)
|
|
GS195576: GO:0016791 phosphatase activity
|
|
GS83994: cocaine seizure 1 (Cosz1, Published QTL, Chr 9)
|
|
GS178357: GO:0071842 cellular component organization at cellular level
|
|
GS135730: dietary obesity 2 (Dob2, Published QTL Chr 9)
|
|
GS136348: nociceptive sensitivity inflammatory QTL 1 (Nociq1, Published QTL Chr 9)
|
|
GS169114: MP:0004196 abnormal prenatal growth/weight/body size
|
|
GS188136: GO:0048858 cell projection morphogenesis
|
|
GS197017: GO:0032990 cell part morphogenesis
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS136431: pulmonary adenoma susceptibility 4 (Pas4, Published QTL Chr 9)
|
|
GS207614: GO:0016023 cytoplasmic membrane-bounded vesicle
|
|
GS179362: GO:0005929 cilium
|
|
GS136104: liver cholesterol 1 (Lcho1, Published QTL Chr 9)
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS136098: long bones 8 (Lbn8, Published QTL Chr 9)
|
|
GS136857: tri-nitrobenzene sulfonic acid susceptible 1 (Tnbs1, Published QTL Chr 9)
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS136121: life span 1 (Lifespan1, Published QTL Chr 9)
|
|
GS186744: GO:0043226 organelle
|
|
GS182835: GO:0005622 intracellular
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS195199: GO:0005634 nucleus
|
|
GS209634: GO:0015630 microtubule cytoskeleton
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS209525: GO:0032989 cellular component morphogenesis
|
|
GS121379: Testosterone Propionate interacting genes (MeSH:D043343) in CTD
|
|
GS84233: METH responses for body temperature (Published QTL, Chr 9)
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS136558: Plasmodium yoelli malaria resistance (Pymr, Published QTL Chr 9)
|
|
GS135375: body length 5 (Bdln5, Published QTL Chr 9)
|
|
GS135822: ethanol conditioned taste aversion 8 (Etohcta8, Published QTL Chr 9)
|
|
GS136007: haloperidol-induced catalepsy 1 (Hpic1, Published QTL Chr 9)
|
|
GS184010: GO:0030030 cell projection organization
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS192609: GO:0031982 vesicle
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS136940: vertebral trabecular bone trait 8 (Vtbt8, Published QTL Chr 9)
|
|
GS205321: GO:0031410 cytoplasmic vesicle
|
|
GS200476: GO:0005932 microtubule basal body
|
|
GS185024: GO:0044463 cell projection part
|
|
GS863: Differential expression across development in Sey Pax6 mutants and controls in an inverted-U (downward parabola).
|
|
GS84226: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS84230: cocaine seizure (Published QTL, Chr 9)
|
|
GS196129: GO:0005929 cilium
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS198206: GO:0060271 cilium morphogenesis
|
|
GS127938: Striatum - Allen Mouse Brain Atlas
|
|
GS201839: GO:0044463 cell projection part
|
|
GS184447: GO:0044424 intracellular part
|
|
GS191180: GO:0005768 endosome
|
|
GS136710: susceptibility to lung cancer 11 (Sluc11, Published QTL Chr 9)
|
|
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS177598: GO:0043412 macromolecule modification
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS136840: T lymphocyte fraction (Tlf, Published QTL Chr 9)
|
|
GS182234: GO:0036211 protein modification process
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS84235: ethanol withdrawal (Published QTL, Chr 9)
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS135288: alcohol response 4 (Alcrsp4, Published QTL Chr 9)
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS136911: vertebral morphology and mechanical traits 16 (Vmmt16, Published QTL Chr 9)
|
|
GS183803: GO:0044267 cellular protein metabolic process
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS189020: GO:0016311 dephosphorylation
|
|
GS181416: GO:0060271 cilium morphogenesis
|
|
GS169833: MP:0005380 embryogenesis phenotype
|
|
GS182834: GO:0005623 cell
|
|
GS135662: cocaine seizure 1 (Cosz1, Published QTL Chr 9)
|
|
GS198370: GO:0042578 phosphoric ester hydrolase activity
|
|
GS178448: GO:0005634 nucleus
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS209550: GO:0031982 vesicle
|
|
GS196941: GO:0008150 biological_process
|
|
GS208043: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS199634: GO:0005623 cell
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS135710: diabetes susceptibility QTL 8 (Dbsq8, Published QTL Chr 9)
|
|
GS84229: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS204290: GO:0004721 phosphoprotein phosphatase activity
|
|
GS201256: GO:0044422 organelle part
|
|
GS136768: streptozotocin induced diabetes susceptibility 2 (Stzid2, Published QTL Chr 9)
|
|
GS162897: MP:0003984 embryonic growth retardation
|
|
GS201431: GO:0005515 protein binding
|
|
GS208092: GO:0005768 endosome
|
|
GS84227: METH responses for body temperature (Published QTL, Chr 9)
|
|
GS187422: GO:0004725 protein tyrosine phosphatase activity
|
|
GS128581: BECs at LORR Recovery Chr# 9
|
|
GS136461: postnatal body weight growth 4 (Pbwg4, Published QTL Chr 9)
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS191954: GO:0005856 cytoskeleton
|
|
GS135588: P. chabaudi malaria resistance QTL 1 (Char1, Published QTL Chr 9)
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS135478: bone response to mechanical loading 11 (Brml11, Published QTL Chr 9)
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS83979: cocaine related behavior 10 (Cocrb10, Published QTL, Chr 9)
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS165160: MP:0006207 embryonic lethality during organogenesis
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS14928: Genes exhibiting decreased expression in the adult rats exposed to prenatal ethanol
|
|
GS169603: MP:0001672 abnormal embryogenesis/ development
|
|
GS84231: METH responses for home cage activity (Published QTL, Chr 9)
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS188465: GO:0031410 cytoplasmic vesicle
|
|
GS136737: submucosal gland distribution 1 (Smgd1, Published QTL Chr 9)
|
|
GS136912: vertebral morphology and mechanical traits 17 (Vmmt17, Published QTL Chr 9)
|
|
GS136822: triglyceride QTL 2 (Tgq2, Published QTL Chr 9)
|
|
GS135325: age related thymic involution 1 (Arti1, Published QTL Chr 9)
|
|
GS196806: GO:0032502 developmental process
|
|
GS127927: Hypothalamus - Allen Mouse Brain Atlas
|
|
GS203594: GO:0043226 organelle
|
|
GS136371: obesity QTL 18 (Obq18, Published QTL Chr 9)
|
|
GS136666: skin tumor susceptibility 6 (Skts6, Published QTL Chr 9)
|
|
GS84234: METH responses for body temperature (Published QTL, Chr 9)
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS127924: Cerebral cortex - Allen Mouse Brain Atlas
|
|
GS194087: GO:0003674 molecular_function
|
|
GS84228: alcohol response 4 (Alcrp4, Published QTL, Chr 9)
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS180001: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS36024: Neocortex Gene expression correlates of Light-Dark Box Total seconds spent in dark compartment in Females BXD
|
|
GS136243: methamphetamine response QTL 2 (Marq2, Published QTL Chr 9)
|
|
GS192471: GO:0048869 cellular developmental process
|
|
GS180166: GO:0008152 metabolic process
|
|
GS184129: GO:0006470 protein dephosphorylation
|
|
GS135321: accelerator of polyoma-induced mammary tumors 2 (Apmt2, Published QTL Chr 9)
|
|
GS135429: bone mineral density 10 (Bmd10, Published QTL Chr 9)
|
|
GS127936: Striatum ventral region - Allen Mouse Brain Atlas
|
|
GS191552: GO:0042995 cell projection
|
|
GS195214: GO:0009987 cellular process
|
|
GS184452: GO:0044422 organelle part
|
|
GS180034: GO:0032502 developmental process
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS36054: Neocortex Gene expression correlates of Light- Dark Box Total seconds spent in light compartment in Females BXD
|
|
GS191135: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS198263: GO:0005488 binding
|
|
GS200809: GO:0030030 cell projection organization
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS181578: GO:0042578 phosphoric ester hydrolase activity
|
|
GS136089: lean body mass 15 (Lbm15, Published QTL Chr 9)
|
|
GS84225: METH responses for home cage activity (Published QTL, Chr 9)
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS166535: MP:0010865 prenatal growth retardation
|
|
GS208302: GO:0005815 microtubule organizing center
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS127939: Thalamus - Allen Mouse Brain Atlas
|
|
GS188751: GO:0044430 cytoskeletal part
|
|
GS180164: GO:0008150 biological_process
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS209555: GO:0031988 membrane-bounded vesicle
|
|
GS167505: MP:0008762 embryonic lethality
|
|
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS180237: GO:0032990 cell part morphogenesis
|
|
GS186562: GO:0009653 anatomical structure morphogenesis
|
|
GS204286: GO:0004725 protein tyrosine phosphatase activity
|
|
GS164262: MP:0002080 prenatal lethality
|
|
GS84236: METH responses for chewing (Published QTL, Chr 9)
|
|
GS208482: GO:0042995 cell projection
|
|
GS136044: insulin dependent diabetes susceptibility 2 (Idd2, Published QTL Chr 9)
|
|
GS193294: GO:0000902 cell morphogenesis
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS135516: "body weight, QTL 6" (Bwq6, Published QTL Chr 9)
|
|
GS204996: GO:0048858 cell projection morphogenesis
|
|
GS166154: MP:0011098 complete embryonic lethality during organogenesis
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS179830: GO:0006464 cellular protein modification process
|
|
GS193268: GO:0005575 cellular_component
|
|
GS136324: non-heme iron levels 5 (Nhil5, Published QTL Chr 9)
|
|
GS178819: GO:0016791 phosphatase activity
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS205610: GO:0044430 cytoskeletal part
|
|
GS136534: promotion susceptibility QTL 1 (Psl1, Published QTL Chr 9)
|
|
GS187426: GO:0004721 phosphoprotein phosphatase activity
|
|
GS210237: GO:0000902 cell morphogenesis
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS191106: GO:0044464 cell part
|
|
GS191379: GO:0005815 microtubule organizing center
|
|
GS177570: GO:0016043 cellular component organization
|
|
GS192584: GO:0032989 cellular component morphogenesis
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
|
|
GS168593: MP:0002088 abnormal embryonic growth/weight/body size
|
|
GS183673: GO:0005932 microtubule basal body
|